Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 4

    1.

    A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.

    Reifel-Miller A, Otto K, Hawkins E, Barr R, Bensch WR, Bull C, Dana S, Klausing K, Martin JA, Rafaeloff-Phail R, Rafizadeh-Montrose C, Rhodes G, Robey R, Rojo I, Rungta D, Snyder D, Wilbur K, Zhang T, Zink R, Warshawsky A, Brozinick JT.

    Mol Endocrinol. 2005 Jun;19(6):1593-605. Epub 2005 Apr 14.PMID: 15831517 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Biochemical regulation of mammalian AMP-activated protein kinase activity by NAD and NADH.

    Rafaeloff-Phail R, Ding L, Conner L, Yeh WK, McClure D, Guo H, Emerson K, Brooks H.

    J Biol Chem. 2004 Dec 17;279(51):52934-9. Epub 2004 Sep 30.PMID: 15465812 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Identification of novel genes differentially expressed in omental fat of obese subjects and obese type 2 diabetic patients.

    Corominola H, Conner LJ, Beavers LS, Gadski RA, Johnson D, Caro JF, Rafaeloff-Phail R.

    Diabetes. 2001 Dec;50(12):2822-30.PMID: 11723066 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes.

    Statnick MA, Beavers LS, Conner LJ, Corominola H, Johnson D, Hammond CD, Rafaeloff-Phail R, Seng T, Suter TM, Sluka JP, Ravussin E, Gadski RA, Caro JF.

    Int J Exp Diabetes Res. 2000;1(2):81-8.PMID: 11469400 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...